Listen carefully to what Pfizer CEO Albert Bourla has to say about the NEXT breakthrough in vaccines.
They'll make the money if they're marketed as preventative treatments. It'll be slim pickings if it's only to stage 3 or 4 or whatever, and the hoo hah ensues about whether the NHS can afford it. I bet they try the "if you are eligible" ploy.
They'll make the money if they're marketed as preventative treatments. It'll be slim pickings if it's only to stage 3 or 4 or whatever, and the hoo hah ensues about whether the NHS can afford it. I bet they try the "if you are eligible" ploy.